Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
522 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Juan City Hospital
San Juan, Puerto Rico
- Providence Hospital
Mobile, Alabama, United States
- Sparks Regional Medical Center
Fort Smith, Arkansas, United States
- East Bay Medical Oncology Hematology Medical Associates-Antioch
Antioch, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Adventist Health Cancer Care Center Chico
Chico, California, United States
- Community Cancer Institute
Clovis, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Memorial Medical Center
Modesto, California, United States
- El Camino Hospital
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- East Bay Medical Oncology Hematology Medical Associates Inc-Pleasant Hill
Pleasant Hill, California, United States
- John Muir Health Cancer Medical Group
Pleasant Hill, California, United States
- Valley Care Health System - Pleasanton
Pleasanton, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- Pomona Valley Hospital Medical Center
Pomona, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Zuckerberg San Francisco General Hospital
San Francisco, California, United States
- East Bay Medical Oncology Hematology Associates Inc
San Leandro, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
- Saint Helena Hospital
St. Helena, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Sept 2008
- Primary completion
- 30 Jun 2014
- Completion
- 1 May 2025
- Last update posted
- 23 May 2025
- Registered enrollment
- 394
- Registry id
- NCT00601900
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.